Madrigal Pharmaceuticals Stock Price History

MDGL Stock  USD 341.62  6.49  1.94%   
Below is the normalized historical share price chart for Madrigal Pharmaceuticals extending back to February 06, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Madrigal Pharmaceuticals stands at 341.62, as last reported on the 23rd of March, with the highest price reaching 344.19 and the lowest price hitting 330.03 during the day.
IPO Date
6th of February 2007
200 Day MA
284.6341
50 Day MA
328.357
Beta
(0.41)
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Madrigal Stock, it is important to understand the factors that can impact its price. Madrigal Pharmaceuticals appears to be very steady, given 3 months investment horizon. Madrigal Pharmaceuticals has Sharpe Ratio of 0.0571, which conveys that the firm had a 0.0571 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Madrigal Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise Madrigal Pharmaceuticals' Risk Adjusted Performance of 0.063, downside deviation of 4.21, and Mean Deviation of 3.0 to check out if our risk estimates are consistent with your expectations.
  
At this time, Madrigal Pharmaceuticals' Common Stock is quite stable compared to the past year. Stock Based Compensation is expected to rise to about 83.9 M this year, although the value of Sale Purchase Of Stock will most likely fall to about 256.7 K. . At this time, Madrigal Pharmaceuticals' Price Book Value Ratio is quite stable compared to the past year. Price To Book Ratio is expected to rise to 9.14 this year, although the value of Price Earnings Ratio will most likely fall to (14.79). Madrigal Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0571

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsMDGL
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.26
  actual daily
38
62% of assets are more volatile

Expected Return

 0.24
  actual daily
4
96% of assets have higher returns

Risk-Adjusted Return

 0.06
  actual daily
4
96% of assets perform better
Based on monthly moving average Madrigal Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Madrigal Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book
9.999
Enterprise Value Ebitda
(8.32)
Price Sales
41.8748
Shares Float
11.4 M
Wall Street Target Price
414.0667

Madrigal Pharmaceuticals Stock Price History Chart

There are several ways to analyze Madrigal Stock price data. The simplest method is using a basic Madrigal candlestick price chart, which shows Madrigal Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 26, 2025355.88
Lowest PriceJanuary 16, 2025272.79

Madrigal Pharmaceuticals March 23, 2025 Stock Price Synopsis

Various analyses of Madrigal Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Madrigal Stock. It can be used to describe the percentage change in the price of Madrigal Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Madrigal Stock.
Madrigal Pharmaceuticals Price Daily Balance Of Power 0.46 
Madrigal Pharmaceuticals Price Rate Of Daily Change 1.02 
Madrigal Pharmaceuticals Price Action Indicator 7.76 

Madrigal Pharmaceuticals March 23, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Madrigal Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Madrigal Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Madrigal Stock and then apply it to test your longer-term investment strategies against Madrigal.

Madrigal Stock Price History Data

The price series of Madrigal Pharmaceuticals for the period between Mon, Dec 23, 2024 and Sun, Mar 23, 2025 has a statistical range of 83.09 with a coefficient of variation of 5.7. The daily prices for the period are spread out with arithmetic mean of 323.97. The median price for the last 90 days is 327.35. The company underwent 1:35 stock split on 25th of July 2016. Madrigal Pharmaceuticals issued dividends to stockholders on 2016-07-25.
OpenHighLowCloseVolume
03/23/2025
 331.93  344.19  330.03  341.62 
03/21/2025 331.93  344.19  330.03  341.62  271,750 
03/20/2025 339.42  342.57  334.94  335.13  163,657 
03/19/2025 337.48  341.18  332.17  340.77  369,113 
03/18/2025 338.40  343.56  331.11  338.54  167,836 
03/17/2025 350.00  350.00  336.96  342.44  291,826 
03/14/2025 328.50  348.35  326.70  348.35  382,056 
03/13/2025 325.99  332.40  321.27  323.02  485,517 
03/12/2025 343.75  344.17  322.40  327.31  577,735 
03/11/2025 329.16  336.22  315.02  335.39  528,274 
03/10/2025 323.04  333.37  322.02  329.16  279,859 
03/07/2025 327.74  339.08  322.00  331.41  419,416 
03/06/2025 341.01  350.00  328.77  328.77  344,829 
03/05/2025 324.00  348.54  319.92  347.28  625,982 
03/04/2025 310.33  327.88  299.56  321.32  679,498 
03/03/2025 335.00  335.40  313.02  313.47  524,103 
02/28/2025 332.00  342.27  329.80  341.27  330,378 
02/27/2025 361.38  366.80  335.03  335.74  471,322 
02/26/2025 335.00  377.46  331.03  355.88  1,188,474 
02/25/2025 320.42  320.54  309.36  309.49  368,996 
02/24/2025 334.37  334.37  319.02  322.14  313,721 
02/21/2025 355.00  355.00  336.23  336.23  257,041 
02/20/2025 343.44  351.05  337.82  351.03  217,486 
02/19/2025 339.76  344.06  334.13  343.63  604,930 
02/18/2025 337.19  341.02  334.50  339.87  166,911 
02/14/2025 353.98  354.49  334.67  337.20  372,393 
02/13/2025 343.80  352.99  339.30  351.71  227,215 
02/12/2025 326.52  340.18  325.87  340.17  457,286 
02/11/2025 336.71  336.71  327.12  331.79  315,532 
02/10/2025 337.35  338.93  333.00  337.56  185,259 
02/07/2025 330.25  334.44  325.37  332.72  306,567 
02/06/2025 340.00  349.28  329.99  330.27  349,538 
02/05/2025 323.21  342.27  323.21  339.97  548,973 
02/04/2025 325.89  334.03  322.00  323.00  508,858 
02/03/2025 325.86  335.57  322.00  325.47  313,205 
01/31/2025 339.52  347.20  334.02  334.80  262,018 
01/30/2025 333.01  342.00  324.47  338.29  367,164 
01/29/2025 324.50  327.28  320.62  326.33  243,324 
01/28/2025 317.38  328.50  311.64  327.35  385,852 
01/27/2025 304.00  314.59  300.00  310.92  558,426 
01/24/2025 337.56  343.54  324.04  328.14  493,383 
01/23/2025 324.75  346.04  313.72  340.14  662,774 
01/22/2025 309.63  324.98  309.47  324.71  456,084 
01/21/2025 293.23  308.46  282.88  307.08  489,602 
01/17/2025 273.61  301.44  270.51  293.64  866,116 
01/16/2025 275.00  277.50  266.52  272.79  384,861 
01/15/2025 280.83  282.05  266.44  274.41  768,870 
01/14/2025 304.80  305.00  273.85  274.12  577,128 
01/13/2025 334.59  334.59  282.68  303.71  1,009,308 
01/10/2025 323.05  343.97  323.02  338.91  449,256 
01/08/2025 320.65  337.06  319.01  333.39  424,761 
01/07/2025 322.17  325.00  315.02  323.24  173,864 
01/06/2025 318.49  323.48  312.07  320.81  203,077 
01/03/2025 315.41  322.48  315.41  319.69  219,459 
01/02/2025 310.71  320.41  309.54  313.78  311,016 
12/31/2024 316.27  316.98  305.02  308.57  198,732 
12/30/2024 308.73  315.27  306.02  311.62  251,366 
12/27/2024 310.00  317.67  308.12  313.11  327,585 
12/26/2024 310.17  314.64  308.63  314.04  201,725 
12/24/2024 310.55  313.96  307.74  312.00  108,171 
12/23/2024 310.81  311.18  302.16  310.87  235,980 

About Madrigal Pharmaceuticals Stock history

Madrigal Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Madrigal is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Madrigal Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Madrigal Pharmaceuticals stock prices may prove useful in developing a viable investing in Madrigal Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding21.3 M22.3 M
Net Loss-265.8 M-252.5 M

Madrigal Pharmaceuticals Quarterly Net Working Capital

863.65 Million

Madrigal Pharmaceuticals Stock Technical Analysis

Madrigal Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Madrigal Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Madrigal Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module

Madrigal Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Madrigal Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Madrigal Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Madrigal to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Madrigal Pharmaceuticals is a strong investment it is important to analyze Madrigal Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Madrigal Pharmaceuticals' future performance. For an informed investment choice regarding Madrigal Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Madrigal Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Madrigal Pharmaceuticals. If investors know Madrigal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Madrigal Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(22.31)
Revenue Per Share
8.468
Return On Assets
(0.37)
Return On Equity
(0.80)
The market value of Madrigal Pharmaceuticals is measured differently than its book value, which is the value of Madrigal that is recorded on the company's balance sheet. Investors also form their own opinion of Madrigal Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Madrigal Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Madrigal Pharmaceuticals' market value can be influenced by many factors that don't directly affect Madrigal Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Madrigal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Madrigal Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Madrigal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.